Human Health Holdings Ltd.

Human Health Holdings Ltd.

HHKEX:1419
0.76
HKD
0.00
(0.00%)
299.85MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.32
1.44
1.7
1.69
1.33
1.43
1.42
1.2
1.72
2.96
2.64
1.56
1.7
- -
Basic EPS, GAAP
0.13
0.15
0.13
0.08
0.04
0.07
0.07
-0.11
0.38
0.99
0.48
0.06
0.07
- -
Free Cash Flow per Basic Share
0.13
0.13
0.2
0.06
0.03
0.11
0.11
0.07
0.19
0.58
1.53
-0.07
0.24
- -
Dividend per Share
0.07
0.14
0.02
0.17
0.03
0.02
0.03
0.03
- -
0.12
0.3
0.16
0.03
- -
Book Value per Share
0.24
0.25
0.24
0.59
0.71
0.76
0.83
0.68
1.08
1.95
2.13
2.02
2.06
2.07
Tangible Book Value per Share
0.24
0.25
0.1
0.46
0.58
0.64
0.72
0.58
0.98
1.86
2.04
1.93
1.85
1.86
Basic Weighted Avg Shares
253
253
253
295
362
362
372
380
380
380
380
380
380
380
Sales/Revenue/Turnover
334
365
430
499
481
518
529
454
655
1,122
1,002
591
644
- -
Operating Margin (%)
12.33
13.36
12.22
10.52
5.01
7.39
6.79
-3.35
24.84
37.48
24.64
1.06
3.73
- -
Depreciation Expense
6
6
7
9
9
10
12
75
68
63
75
68
68
- -
Net Income, GAAP
34
39
34
23
13
24
27
-40
144
375
181
24
26
- -
Effective Tax Rate (%)
16.05
17.43
20.94
34.55
37.35
27.12
24.12
- -
14.43
15.71
24.28
8.94
11.05
- -
Profit Margin (%)
10.21
10.61
7.85
4.7
2.8
4.65
5.04
-8.9
22.06
33.46
18.05
4.09
4.09
- -
Working Capital
73
76
18
126
169
180
128
62
231
431
448
398
384
415
LT Debt
- -
- -
- -
- -
- -
- -
- -
34
14
107
98
66
69
54
Total Equity
94
98
85
215
257
274
314
259
410
742
808
767
782
786
Return on Invested Capital (%)
- -
39.74
35.9
17.47
5.92
10.3
8.91
- -
33.16
47.17
17.86
0.58
2.35
- -
Return on Capital (%)
- -
38.31
29.36
12.63
5.63
9.44
9.05
- -
35.06
53.68
19.48
3.33
3.48
- -
Return on Common Equity (%)
- -
44.56
38.99
15.65
5.74
9.12
9.07
-14.1
43.17
65.15
23.33
3.07
3.4
- -

Capital Structure

HKD

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
ST Debt
75
66
66
LT Borrowings
- -
- -
- -
LT Finance Leases
57
69
54
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
380
380
380
Market Capitalization
296
315
300

Working Capital

HKD

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
Total Current Assets
611
588
609
Cash, Cash Equivalents & STI
480
440
475
Accounts Receivable, Net
58
62
61
Inventories
24
25
22
Total Current Liabilities
193
204
194
Payables & Accruals
- -
- -
- -
ST Debt
75
66
66
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
32.18%
29%
1.97%
Free Cash Flow
15.56%
-0.77%
-445.33%
Net Income, GAAP
-66.28%
-85.51%
8.88%
Sales/Revenue/Turnover
8.11%
14.6%
9.07%
Total Cash Common Dividend
- -
1,645.83%
-82.5%

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
591
2025
- -
- -
644
2026
- -
- -
- -

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.06
2025
- -
- -
0.07
2026
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.16
2025
- -
- -
0.03
2026
- -
- -
- -

Company Description

CEO
Kin Ping Chan
Full Time Employees
512
Sector
Health services
Industry
Medical/Nursing services
Address
Enterprise Square Two Hong Kong Hong Kong
IPO Date
Apr 1, 2016
Business
Human Health Holdings Limited operates as a comprehensive healthcare service provider primarily in Hong Kong. The company offers a broad range of medical services including general practice services such as general consultation, diagnostics, preventative health, minor procedures, vaccinations, and physical check-ups. It provides specialty medical services across various disciplines including general surgery, orthopedics and traumatology, ophthalmology, otorhinolaryngology, pediatrics, obstetrics and gynecology, gastroenterology and hepatology, cardiology, pediatric surgery, dermatology and venereology, psychiatry, radiology, urology, nephrology, neurosurgery, anesthesiology, and oncology. In addition, Human Health offers extensive dental care services covering general dentistry, dental implants, root canal therapy, microscopic endodontics, crown and bridge, oral surgery, orthodontic treatment, 3D guided implant and surgery, intraoral digital impressions, CAD/CAM dentistry, laser dentistry, cone-beam computed tomography, and cosmetic and specialist dentistry. The company also provides physiotherapy, medical aesthetics, nutritionist services, health and wellness programs, endoscopy, and advanced medical diagnostics. Founded in 1996, Human Health Holdings is headquartered in Hong Kong and is engaged in serving individuals and corporate clients with a full spectrum of prevention, healthcare, diagnosis, and treatment services. Recent major developments include a strategic network expansion with openings of new medical centers in key districts of Hong Kong, which has driven revenue growth. The company has significantly increased its digital investments by upgrading its IT infrastructure to accelerate digital transformation and launched a proprietary integrated clinical platform across its general and specialty medical centers to enhance patient care and operational efficiency. Additionally, it introduced an omnichannel messaging platform, including WhatsApp inquiry functions, to improve public inquiry response times and customer engagement. Human Health maintains strong collaborations with the Hong Kong Government on public health initiatives such as seasonal influenza vaccination subsidies, chronic disease co-care, colorectal cancer screening, and rehabilitation programs for injured workers. These efforts aim to expand healthcare accessibility and service quality. The company also reported improved financial performance with increased revenue and net profit on a recent fiscal basis, indicating operational improvements through cost management and process optimization. Human Health Holdings operates through a network of medical and dental centers in Hong Kong, servicing a diverse customer base including individual patients and corporate groups. The company emphasizes a people-oriented corporate culture and leverages its comprehensive infrastructure and management expertise to continuously expand and enhance its healthcare offerings. This description reflects the latest available public information through 2025 on Human Health Holdings Limited and its ongoing strategic and operational developments.